Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 26;8(2):101128.
doi: 10.1016/j.adro.2022.101128. eCollection 2023 Mar-Apr.

Linear Energy Transfer and Relative Biological Effectiveness Investigation of Various Structures for a Cohort of Proton Patients With Brain Tumors

Affiliations

Linear Energy Transfer and Relative Biological Effectiveness Investigation of Various Structures for a Cohort of Proton Patients With Brain Tumors

Ana Vaniqui et al. Adv Radiat Oncol. .

Abstract

Purpose: The current knowledge on biological effects associated with proton therapy is limited. Therefore, we investigated the distributions of dose, dose-averaged linear energy transfer (LETd), and the product between dose and LETd (DLETd) for a patient cohort treated with proton therapy. Different treatment planning system features and visualization tools were explored.

Methods and materials: For a cohort of 24 patients with brain tumors, the LETd, DLETd, and dose was calculated for a fixed relative biological effectiveness value and 2 variable models: plan-based and phenomenological. Dose threshold levels of 0, 5, and 20 Gy were imposed for LETd visualization. The relationship between physical dose and LETd and the frequency of LETd hotspots were investigated.

Results: The phenomenological relative biological effectiveness model presented consistently higher dose values. For lower dose thresholds, the LETd distribution was steered toward higher values related to low treatment doses. Differences up to 26.0% were found according to the threshold. Maximum LETd values were identified in the brain, periventricular space, and ventricles. An inverse relationship between LETd and dose was observed. Frequency information to the domain of dose and LETd allowed for the identification of clusters, which steer the mean LETd values, and the identification of higher, but sparse, LETd values.

Conclusions: Identifying, quantifying, and recording LET distributions in a standardized fashion is necessary, because concern exists over a link between toxicity and LET hotspots. Visualizing DLETd or dose × LETd during treatment planning could allow for clinicians to make informed decisions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relative biological effectiveness (RBE) dose distributions for a selection of organs at risk, calculated using the constant clinical factor of 1.1 (red), McNamara's model (green; α/β of 2 Gy), and Unkelbach's model (blue). Both histograms and bars present the frequency distribution (differential dose and number of voxels per unit of RBE dose). The boxplots show the interquartile range, median, and outliers.
Figure 2
Figure 2
Dose-averaged linear energy transfer (LETd) distributions for a selection of organs at risk, calculated using dose thresholds of 0 Gy (red), 5 Gy (blue), and 20 Gy (green). Both histograms and bars present the frequency distribution, or the number of voxels per unit of LETd value. The boxplots show the interquartile range, median, and outliers according to the individual distribution.
Figure 3
Figure 3
Product between dose and dose-averaged linear energy transfer (DLETd) distributions for a selection of organs at risk, calculated using 0 Gy (red), 5 Gy (blue), and 20 Gy (green) relative biological effectiveness dose threshold. Both histograms and bars present the frequency distribution, or the number of voxels per unit of DLETd value. The boxplots show the interquartile range, median, and outliers according to the individual distribution.
Figure 4
Figure 4
(A) Example patient with planning dose, dose-averaged linear energy transfer (LETd), and product between dose and dose-averaged linear energy transfer (DLETd) distributions with the optic chiasm contoured in yellow. (B) Distribution of dose and LETd values for the chiasm (orange) and pituitary (blue) for all patients (N = 24) in the study. (C, D) Relationship between mean values of dose, LETd, and DLETd (for dose threshold of 20 Gy) for the chiasm and pituitary gland. Dose, LETd, and DLETd are represented by the blue, red, and green axes, respectively.
Figure 5
Figure 5
Dose and dose-averaged linear energy transfer (LETd) histograms of a selection of investigated structures for a single patient. Dose and LETd values are represented on the x- and y-axes, respectively, for each subplot. Next to each structure name, the percentage of voxels >0 is indicated, as used for the graph. The color bar on the right indicates the frequency in the same scale for all plots.
Figure 6
Figure 6
(A) Clinical target volume (CTV; gray color map) and periventricular space (PVS; multiple colors) dose-averaged linear energy transfer (LETd) distribution spatial representation. (B) Dose–LETd histograms of the PVS for different patients. Dose and LETd values are represented on the x- and y-axes, respectively, for each subplot. The color bar on the right indicates the frequency in the same scale for all plots.

References

    1. Paganetti H, Blakely E, Carabe-Fernandez A, et al. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019;46:e53–e78. - PMC - PubMed
    1. Luhr A, von Neubeck C, Pawelke J, et al. Radiobiology of proton therapy: Results of an international expert workshop. Radiother Oncol. 2018;128:56–67. - PubMed
    1. Zhang J, Si J, Gan L, et al. Harnessing the targeting potential of differential radiobiological effects of photon versus particle radiation for cancer treatment. J Cell Physiol. 2021;236:1695–1711. - PubMed
    1. Sorensen BS, Bassler N, Nielsen S, et al. Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo. Acta Oncol. 2017;56:1387–1391. - PubMed
    1. Mohan R, Peeler CR, Guan F, et al. Radiobiological issues in proton therapy. Acta Oncol. 2017;56:1367–1373. - PMC - PubMed

LinkOut - more resources